PMID: 11901893Mar 21, 2002Paper

The best of 2001. Heart failure

Archives des maladies du coeur et des vaisseaux
Y Juillière

Abstract

This year the prevalence, prognosis and the cost of left ventricular function have been clarified. The significance of B natiuretic peptide has been confirmed. The influence of race on the sensitivity to different therapeutic measures has been brought up. Tobacco and diabetes appear as risk factors in cardiac insufficiency. The importance of parietal thickening regarding hypertrophic cardiomyopathy is beginning to be debated, and the risk associated with a new pregnancy in women affected by dilated cardiomyopathy of the peripartum period has been demonstrated. The significance of betablockers is confirmed, although that of angiotensin II receptor antagonists remains a source of questions, despite several advances. Endothelin receptor antagonists present divergent results. Ventricular resynchronisation advances, but its beneficial role regarding the reduction of morbidity and mortality remains to be proved.

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Chinese Medical Sciences Journal = Chung-kuo I Hsüeh K'o Hsüeh Tsa Chih
Jiaxin YangXuming Bian
The Veterinary Clinics of North America. Equine Practice
L Chris Sanchez
Puerto Rico Health Sciences Journal
Miguel A Rodríguez-González, Arturo Medina-Ruíz
Critical Care Medicine
S Murali, Marie R Baldisseri
© 2022 Meta ULC. All rights reserved